These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30410225)

  • 1. Assessment of
    Aly SE; Hussein HA; Aly AM; Abdel-Baky MH; El-Sanousi AA
    Vet World; 2018 Sep; 11(9):1222-1228. PubMed ID: 30410225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of minimum hemagglutinin units in an inactivated Newcastle disease virus vaccine for clinical protection of chickens from exotic Newcastle disease virus challenge.
    Liljebjelke KA; King DJ; Kapczynski DR
    Avian Dis; 2008 Jun; 52(2):260-8. PubMed ID: 18646455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation.
    Claassen I; Maas R; Oei H; Daas A; Milne C
    Pharmeuropa Bio; 2004 Dec; 2004(1):1-15. PubMed ID: 15659281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen content of inactivated Newcastle disease oil emulsion vaccines as an in vitro indicator of potency.
    Maas R; van Diepen M; Komen M; Oei H; Claassen I
    Dev Biol (Basel); 2002; 111():313-8. PubMed ID: 12678255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of binary ethylenimine-inactivated vaccines of Gianyar-1/AK/2014 virulent strain in protecting chickens against Tabanan-1/ARP/2017 virulent Newcastle disease virus isolates.
    Adi AAAM; Astawa INM; Putra IGAA
    Vet World; 2019 Jun; 12(6):758-764. PubMed ID: 31439989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and biological characterization of the immunological potency of Newcastle disease virus oil emulsion-inactivated vaccines prepared from field isolate obtained from vaccinated chickens outbreak.
    Hassan MI; Abd El-Azeem MW; Selim A; Sultan S
    Braz J Microbiol; 2020 Jun; 51(2):815-826. PubMed ID: 31840214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test.
    Jagt HJ; Bekkers ML; van Bommel SA; van der Marel P; Schrier CC
    Biologicals; 2010 Jan; 38(1):128-34. PubMed ID: 19716316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency test of inactivated Newcastle disease vaccines by monoclonal antibody blocking ELISA.
    Horváth E; Czifra G; Nagy E; Engström B; Mérza M
    Vaccine; 1999 Aug; 17(23-24):2969-73. PubMed ID: 10462231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of inactivated Newcastle disease virus vaccines prepared in two different oil-based adjuvants.
    Aljumaili OA; Bello MB; Yeap SK; Omar AR; Ideris A
    Onderstepoort J Vet Res; 2020 Sep; 87(1):e1-e7. PubMed ID: 33054260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains.
    Azab AA; Yehia N; Makhareta M; Samir M; Shoukry A; Elhalem Mohamed AA; Alhag SK; Alwabli AS; El-Saadony MT; El-Tarabily KA; Soliman MA
    Poult Sci; 2023 Oct; 102(10):102952. PubMed ID: 37634266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines.
    Maas RA; de Winter MP; Venema S; Oei HL; Claassen IJ
    Vet Q; 2000 Oct; 22(4):223-7. PubMed ID: 11087135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of an inactivated Newcastle disease virus vaccine encapsulated in poly-(lactic-co-glycolic acid) nanoparticles.
    Ananda Kumar BS; Panickan S; Bindu S; Kumar V; Ramakrishnan S; Saxena S; Shrivastava S; Dandapat S
    Poult Sci; 2023 Jun; 102(6):102679. PubMed ID: 37116285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus.
    Hossain I; Subarna JF; Kabiraj CK; Begum JA; Parvin R; Martins M; Diel DG; Chowdhury EH; Islam MR; Nooruzzaman M
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.